| scholarly article | Q13442814 |
| P50 | author | Giovanni Palladini | Q37839091 |
| Giampaolo Merlini | Q37839101 | ||
| Catherine Klersy | Q43005750 | ||
| Paolo Milani | Q44254925 | ||
| Laura Obici | Q56426698 | ||
| Marco Paulli | Q73293658 | ||
| Francesca Lavatelli | Q80557915 | ||
| P2093 | author name string | Andrea Foli | |
| Patrizia Morbini | |||
| Carlos Fernández de Larrea | |||
| Laura Verga | |||
| Gian Luca Capello | |||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 2239-2244 | |
| P577 | publication date | 2015-01-30 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | A practical approach to the diagnosis of systemic amyloidoses | |
| P478 | volume | 125 |
| Q61445851 | A new genetic variant of hereditary apolipoprotein A-I amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic options |
| Q91891488 | A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis |
| Q47313576 | AL amyloidosis: from molecular mechanisms to targeted therapies |
| Q38809423 | Advances in proteomic study of cardiac amyloidosis: progress and potential. |
| Q36285865 | Application of confocal laser scanning microscopy for the diagnosis of amyloidosis |
| Q33168881 | Cardiac amyloidosis: pathogenesis, clinical context, diagnosis and management options |
| Q64071946 | Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient |
| Q40166313 | Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy. |
| Q94564971 | Diagnosing cardiac amyloidosis in every-day practice: A practical guide for the cardiologist |
| Q26776496 | Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis |
| Q57640668 | Diffuse Peritoneal and Bowel Wall Infiltration by Light Chain-AL Amyloidosis with Omental Calcification Mimicking Abdominal Carcinomatosis - An Elderly Female with Incidental Finding of Light Chain Monoclonal Gammopathy of Undetermined Significance ( |
| Q90428497 | European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias |
| Q48046525 | Factoring in the missing link. |
| Q33763353 | Gastrointestinal Tract Amyloidosis Presenting With Pneumatosis Intestinalis |
| Q89852253 | Hepatic veno-occlusive disease may be a rare characteristic of hepatic involvement in systemic amyloidosis: case report and literature review |
| Q53281859 | How do we improve treatments for patients with amyloidosis using proteomics? |
| Q38970608 | Immunoglobulin Light Chain Systemic Amyloidosis |
| Q38547033 | Improving strategies for the diagnosis of cardiac amyloidosis |
| Q37061542 | In situ characterization of protein aggregates in human tissues affected by light chain amyloidosis: a FTIR microspectroscopy study. |
| Q88645858 | Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis |
| Q91980987 | Inflammatory and Molecular Pathways in Heart Failure-Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis |
| Q48696185 | Investigation and management of IgM and Waldenström-associated peripheral neuropathies: recommendations from the IWWM-8 consensus panel |
| Q38629699 | Labial salivary gland biopsy for diagnosing immunoglobulin light chain amyloidosis: a retrospective analysis. |
| Q52659305 | Light Chain Amyloidosis. |
| Q47672176 | Misidentification of transthyretin and immunoglobulin variants by proteomics due to methyl lysine formation in formalin-fixed paraffin-embedded amyloid tissue |
| Q38779623 | New and developing therapies for AL amyloidosis |
| Q47561519 | New concepts in the treatment and diagnosis of amyloidosis |
| Q55127439 | Novel Therapies in Light Chain Amyloidosis. |
| Q38614967 | Novel strategies for the diagnosis and treatment of cardiac amyloidosis. |
| Q53988051 | Patients with AL amyloidosis and low free light-chain burden have distinct clinical features and outcome. |
| Q58424126 | Patterns of relapse after upfront bortezomib therapy in AL amyloidosis |
| Q58289419 | Prognostication of survival and progression to dialysis in AA amyloidosis |
| Q38613822 | Recent advances in the management of AL Amyloidosis |
| Q37499211 | Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia |
| Q58125099 | Response to bendamustine is associated with a survival advantage in a heavily pretreated patients with AL amyloidosis |
| Q55167558 | Systemic amyloidoses and proteomics: The state of the art. |
| Q38829923 | Systemic amyloidosis: novel therapies and role of biomarkers |
| Q52716113 | The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases. |
| Q64360352 | The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis |
| Q36356006 | The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic |
| Q41677319 | Utility of abdominal skin plus subcutaneous fat and rectal mucosal biopsy in the diagnosis of AL amyloidosis with renal involvement |
| Q88400942 | [How I treat immunoglobulin light chain amyloido-sis] |
Search more.